Search the Newsreel

Henry Schein to announce Q2 2026 results on August 4

Henry Schein, Inc. will release its second-quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026. A live webcast of its earnings conference call will be held on the same day at 8:00 a.m. Eastern time, featuring CEO Fred Lowery …

Black Talon Announces Collaboration with Henry Schein One to Bring Continuous Cyber Readiness to Dental Practices

Black Talon Security has partnered with Henry Schein One's TechCentral to offer its EAGLEi™ continuous threat exposure management platform to dental practices. This collaboration aims to provide advanced cybersecurity tailored for the dental industry, combining TechCentral's IT expertise with Black Talon's security solutions to …

Press Release: Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.m. ET

Henry Schein (HSIC) is scheduled to webcast its Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.M. ET. The article also includes information about Unity Software's Q4 financial results, reporting revenue of $609 million and a quarterly loss of 66 …

Henry Schein stock trades steady as dental and medical distribution margins hold after recent earnings

Henry Schein stock remains stable reflecting consistent demand for dental and medical supplies. Recent quarterly results highlight resilient revenue growth and strong margin management across its key segments, including dental, medical, and animal health. The company's ability to achieve growth through both volume and …

Henry Schein stock trades steady as dental and medical demand supports earnings outlook

Henry Schein's stock remains stable due to consistent demand from dental and medical practices, supported by growing sales and resilient margins. The company's fiscal 2024 results showed a 2.5% revenue growth to $12.0 billion and increased adjusted earnings per share, driven primarily by its …

Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating

Leerink Partners has raised its price target for Henry Schein to $88 from the previous $83, while maintaining a Market Perform rating on the stock. This adjustment reflects the firm's updated outlook on the medical equipment and supplies distributor. Henry Schein specializes in providing …

Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?

Henry Schein (HSIC) is expected to beat its upcoming earnings estimates, continuing a strong trend of exceeding expectations. The company, part of the Zacks Medical - Dental Supplies industry, has a positive Zacks Earnings ESP of +0.41% and a Zacks Rank #2 (Buy), which …

Henry Schein (HSIC) Baird Global Healthcare Conference 2025 Summary

Henry Schein (HSIC) presented at the Baird Global Healthcare Conference 2025, detailing its strategic initiatives like the BOLD+1 program, recovery from a cyber incident, and value creation projects aimed at improving gross profit and SG&A. The company noted a stable global dental market with …

Henry Schein stock trades steady as recent earnings highlight margin resilience

Henry Schein's stock shows stability following its Q1 2026 earnings report, which highlighted revenue growth and resilient operating margins. The company achieved $3.2 billion in net sales, marking a 6% increase year-over-year, driven by strong demand in dental and medical distribution, and contributions from …

Henry Schein stock steady as investors weigh margin trends and dental demand

Henry Schein stock is being analyzed by investors for its balance between robust dental demand and margin pressures stemming from investments and acquisitions. Recent financial reports offer critical data on the company's growth, profitability, and cash generation within the competitive medical and dental distribution …

Henry Schein (HSIC) Q4 2024 earnings summary

Henry Schein's Q4 2024 results revealed stable dental and medical markets, significant operating income from high-growth businesses, and the completion of its 2022–2024 BOLD+1 plan. The company reported Q4 2024 GAAP diluted EPS of $0.74, non-GAAP diluted EPS of $1.19, and projected 2025 sales …

Henry Schein stock stays anchored by 2025 sales and margin trends

Henry Schein's stock performance is currently framed by its 2025 financial figures, including $12.7 billion in sales (a 2.3% reported decline, but a 2.6% increase in constant currency), $774 million in operating income, and diluted EPS of $2.94. These metrics provide a clear baseline …

Henry Schein stock hits 52-week high at 89.34 USD By Investing.com

Henry Schein Inc. (HSIC) stock reached a new 52-week high of $89.34, reflecting a 25.74% total return over the past year. This milestone follows strong first-quarter 2026 earnings, a strategic partnership with GoTu Technology to enhance dental staffing, and positive analyst upgrades from firms …

Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains

Shares of Henry Schein Inc. rose by 1.26% on Thursday, reaching $88.26, marking its sixth consecutive day of gains. Despite this increase, the stock underperformed compared to market competitors as the S&P 500 Index fell 0.51% and the Dow Jones Industrial Average fell 0.20% …

Henry Schein stock reflects steady healthcare distribution business

Henry Schein stock provides investors exposure to a global distributor of dental and medical supplies and technology solutions. The company's business model is characterized by recurring demand for consumables driven by ongoing patient care and a mixed revenue stream from both consumables and larger …

Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?

Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next

Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Henry Schein Reports First Quarter 2026 Financial Results

HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises

Is It Time To Reassess Henry Schein (HSIC) After Recent Share Price Volatility?

Here's How Henry Schein Is Placed Ahead of Q1 Earnings

Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth

Henry Schein (HSIC) 2026 proxy details CEO transition, KKR 16.4% stake and board cuts

Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound?